Asensi-Cantó, A.; López-Abellán, M.D.; Castillo-Guardiola, V.; Hurtado, A.M.; MartÃnez-Penella, M.; Luengo-Gil, G.; Conesa-Zamora, P.
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment. Cancers 2022, 14, 3248.
https://doi.org/10.3390/cancers14133248
AMA Style
Asensi-Cantó A, López-Abellán MD, Castillo-Guardiola V, Hurtado AM, MartÃnez-Penella M, Luengo-Gil G, Conesa-Zamora P.
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment. Cancers. 2022; 14(13):3248.
https://doi.org/10.3390/cancers14133248
Chicago/Turabian Style
Asensi-Cantó, Antonio, MarÃa Dolores López-Abellán, Verónica Castillo-Guardiola, Ana MarÃa Hurtado, Mónica MartÃnez-Penella, Ginés Luengo-Gil, and Pablo Conesa-Zamora.
2022. "Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment" Cancers 14, no. 13: 3248.
https://doi.org/10.3390/cancers14133248
APA Style
Asensi-Cantó, A., López-Abellán, M. D., Castillo-Guardiola, V., Hurtado, A. M., MartÃnez-Penella, M., Luengo-Gil, G., & Conesa-Zamora, P.
(2022). Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment. Cancers, 14(13), 3248.
https://doi.org/10.3390/cancers14133248